ArticleCancer immunology, immunotherapy : CII2023

The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer.

Yohei Nose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.